Ibrexafungerp

Cat. No. M10833

All AbMole products are for research use only, cannot be used for human consumption.

Synonym:

SCY-078; MK-3118

For this product's availability, delivery time and price, please email [email protected] directly or click the "Inquiry Now" button below.

Ibrexafungerp is a novel, orally available glucan synthase inhibitor with in vitro activity against many echinocandin-resistant Candida strains.

Molecular Weight	730.03
Formula	C44H67N5O4
CAS Number	1207753-03-4
Storage	Powder -20°C 3 years ; 4°C 2 years In solvent -80°C 6 months ; -20°C 1 month

Related Anti-infection Products
Torcitabine Torcitabine (2'-Deoxy-L-cytidine) is an antiviral agent. Torcitabine has the potential for chronic hepatitis B virus infection research. Torcitabine (2'-Deoxy-L-cytidine) shows greater inhibition of first strand than second strand DNA synthesis.
ABMA ABMA is a broad-spectrum inhibitor of intracellular toxins and pathogens. ABMA efficiently protects cells against various toxins and pathogens including viruses, intracellular bacteria and parasite.
DDX3-IN-1 DDX3-IN-1 is a DEAD-box polypeptide 3 (DDX3) inhibitor with CC50 values of 50 and 36 μM for HIV and HCV, respectively. DDX3-IN-1 has antiviral activity.
WU-04 WU-04 is a non-covalent inhibitor of SARS-CoV-2, targeting the 3CLpro protein.
MM3122 MM3122 is a selective type II transmembrane serine protease (TMPRSS2) inhibitor with an IC50 value of 0.34 nM.

Catalog